Regeneron: Just me or is the future feeling uncertain?

Been with Regeneron for a while and generally felt pretty secure. But lately, especially with the market conditions and some of the blockbuster drug lifecycle stuff people are talking about, I'm starting to feel a little uneasy. It's not like there are official announcements or anything, but you can just feel a shift. I've noticed a lot more 'strategy discussions' happening at higher levels, and some projects seem to be getting deprioritized or put on hold indefinitely. It's the kind of thing that doesn't directly impact my day-to-day yet, but it makes you wonder what's coming down the pipeline. Are they consolidating, pivoting, or just tightening the belt before a potential downturn? Curious if anyone else, particularly those in senior roles or with visibility into strategic planning, has any thoughts or observations? Is this just the normal biotech cycle, or is there something specific brewing at Regeneon that we should be aware of? Trying to get a better sense of the company's direction and stability moving forward.